 Co-Diagnostics NASDAQ:CODX has said that CoSara Diagnostics Pvt Ltd, its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization CDSCO in India to manufacture and sell its SARAQ Hepatitis C HCV Viral Load Kit as an in vitro diagnostic IVD. CoSaras new real-time HCV PCR test is built on the companys patented CoPrimer technology and designed to be used as an aid in assessing response to antiviral treatments in patients diagnosed with HCV, a disease with no effective vaccine that leads to nearly 300,000 deaths in 2019 according to the World Health Organization WHO. 